Danaher Corporation
Danaher Finalizes Issuance of Multiple Series of Senior Notes
Summary
On June 3, 2026, Danaher Corporation, through its subsidiary DH Masi Finance Inc., completed the issuance of multiple series of senior notes totaling CHF 1.98 billion. The notes, with maturities ranging from 2031 to 2056 and interest rates from 1.65% to 2.51%, were issued in a private placement exempt from Securities Act registration requirements. The net proceeds will be used for general corporate purposes, including working capital, acquisitions, and share repurchases.
Profitelligence Alerts
Get alerts for DHR
Be first to know when Danaher Corporation files with the SEC.
Filing Categories
Advertisement
About Danaher Corporation
Danaher Corporation is a globally recognized science and technology company specializing in the development, design, and manufacturing of diverse industrial and healthcare products. With a primary focus on innovations in diagnostics, life sciences, dental, and environmental and applied solutions, Danaher serves a multitude of industries and market sectors. Its cutting-edge diagnostic equipment aids medical professionals in delivering precise healthcare, while its life sciences tools and technologies propel biomedical research and development. The company's environmental solutions also play a key role in enhancing water quality analysis and management. Headquartered in Washington, D.C., Danaher is renowned for its strong operational culture exemplified by the Danaher Business System (DBS), which emphasizes continuous improvement and sustainable innovation. This approach has solidified Danaher's presence and influence in both developing specialized solutions and improving efficiency across global markets. The company's strategic acquisitions and consistent focus on innovation have positioned it as a leader in delivering essential solutions that drive significant improvements for healthcare, research, and industrial clients.
Official SEC Documents
Advertisement